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A model of K-Ras-initiated lung cancer was used to follow the transition of precancerous
adenoma to adenocarcinoma. In hypoxic, Tgf-β1-rich interiors of adenomas, we show that
adenoma cells divide asymmetrically to produce cancer-generating cells highlighted by epi-
thelial mesenchymal transition and a CD44/Zeb1 loop. In these cells, Zeb1 represses the
Smad inhibitor Zeb2/Sip1, causing Pten loss and launching Tgf-β1 signaling that drives
nuclear translocation of Yap1. Surprisingly, the nuclear polarization of transcription factors
during mitosis establishes parent and daughter fates prior to cytokinesis in sequential
asymmetric divisions that generate cancer cells from precancerous lesions. Mutation or
knockdown of Zeb1 in the lung blocked the production of CD44hi, Zeb1hi cancer-generating
cells from adenoma cells. A CD44/Zeb1 loop then initiates two-step transition of pre-
cancerous cells to cancer cells via a stable intermediate population of cancer-generating cells.
We show these initial cancer-generating cells are independent of cancer stem cells generated
in tumors by p53-regulated reprogramming of existing cancer cells.
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A small population of cells, termed cancer stem cells (CSC)or tumor-initiating cells, have been identified in manytumors, including lung adenocarcinoma (AC)1–4. These
cells can divide asymmetrically to generate cancer cells, while
maintaining their numbers in the tumor. CSC were thought to
arise from the transformation of adult stem cells or progenitor
population persisting in tissues, and these cells, in turn, were
responsible for the generation of initial cancer cells. But, recent
studies demonstrate that existing cancer cells undergo reversible
reprogramming to generate CSC, which are then thought to be
critical for maintaining cancer cell numbers in tumors and gen-
erating new cancer cells following therapy1–3. Thus, a relationship
between CSC generated from reprogramming of existing cancer
cells and the pathway leading to initial cancer cell generation are
still being unraveled.
Although CSC display normal stem cell properties such as
asymmetric division, there are key differences in pathways and
gene expression patterns in CSC vs. stem cells. Perhaps, the
foremost among these differences is tissue stems cells display an
epithelial-like phenotype, and iduced pluripotent stem cells (iPS)
reprogramming to generate stem-like cells requires a
mesenchymal-to-epithelial transition4, whereas CSC are char-
acterized by an opposing epithelial mesenchymal transition
(EMT), which can be driven by induction of EMT transcription
factors such as Zeb12,5. This EMT in CSC is linked to high
expression of CD44, which marks CSC in tumors including breast
and lung cancers6–9, and a positive CD44/Zeb1 loop has been
shown to drive EMT and reprogramming of existing cancer cells
to a CSC phenotype10,11. This loop can be initiated by Tgf-β
induction of Zeb1 in cell culture2, but it is unclear if such a loop is
present or functional in vivo.
We utilized a K-Ras-initiated model of lung AC12 to search for
a CD44/Zeb1 loop in vivo, and address its potential role in cancer
cell generation. Ras pathway mutations, including K-Ras itself
and EGFR, have been widely utilized in mouse models of human
lung AC13. These mutations are mutually exclusive in human
lung AC, suggesting that they are redundant and thus equivalent
in Ras pathway activation in the lung14. Mutations such as Pten
or p53 affect tumor progression in this K-Ras model, and they
have been widely utilized with K-Ras to evaluate their roles in
tumors. Notably, Pten is not mutated in K-Ras-initiated tumors
such as lung and pancreatic AC, but instead, its expression is
somehow repressed as these tumors progress, accounting for Pten
mutation accelerating tumor progression in these mice15–17.
Compound mutation of p53 does not affect cancer cell generation
or their expansion into tumors18,19. Instead, its mutation
allows K-Ras-initiated tumors to transition to metastasis, imply-
ing p53 is acting later to promote cancer cell metastasis in this
model.
As opposed to compound mutations generated simultaneously
in mouse models, mutations are thought to arise sequentially over
a long period in patients. In this regard, it is of note that K-Ras
mutation alone initiates a pathway leading to lung AC in mice,
but with this single mutation, the process is highlighted by a
protracted period of precancerous lesion expansion12,20. In these
mice, precancerous subpleural adenomas form around bronchial
airways (Fig. 1a). AC cells appear later in these adenomas, and
they expand into large tumors that invade airways.
Elegant lineage mapping in the lung has shown both Clara and
ATII cells are the targets of K-Ras transformation responsible for
precancerous adenoma generation21,22. In the absence of con-
current p53 mutation, transformed ATII cells are the only lineage
that transitions to AC, thus AC in this model are derived from
ATII cells. But, as noted above, steps involved in the transition of
ATII-derived adenoma cells to AC are still being unraveled. We
focused our studies on such sites of initial cancer cell generation
within expanding adenomas in the lungs of mice expressing
mutant K-Ras. We found an evidence that a positive CD44/Zeb1
loop is initiated in small clusters of cells derived from asymme-
trically dividing adenoma cells at sites of hypoxia, EMT, and Tgf-
β1 accumulation in the interiors of expanding adenomas. Zeb1
repression of the Smad inhibitor Zeb2/Sip1 launches Tgf-β1
signaling in these cell clusters, and they activate transcription
factors and pathways known to be important for CSC formation.
We show these adenoma-derived cluster cells are initial cancer-
generating cells (CGC), and they, in turn, divide asymmetrically
to produce AC cells. These two sequential asymmetric divisions
that generate cancer cells from precancerous lesions both show
early nuclear polarization of key transcription factors during
mitosis, and resulting asymmetric expression of their target genes
in opposite cell poles then establishes parental and daughter fates
prior to cytokinesis. Mutation or knockdown of Zeb1 in the lung
blocked the production of these Zeb1hi, CD44hi cancer-generating
cluster cells from adenoma cells, in turn inhibiting cancer cell
formation. These results provide evidence that a CD44/Zeb1 loop
is activated in vivo at sites of hypoxia and Tgf-β1 accumulation in
expanding precancerous adenomas, and this loop then initiates a
two-step pathway in which precancerous cells transition to cancer
cells via a stable intermediate population of CGC. We provide
evidence that this population of initial CGC is independent of
CSC that are generated in tumors via p53-regulated reprogram-
ming of existing cancer cells.
Results
An Intermediate Population Arises in the Hypoxic Interior of
Precancerous Adenomas. In response to K-Ras mutation in the
mouse lung, atypical adenomatous hyperplasia (AAH) develops
around bronchial airways, and these cells expanded to form
benign subpleural precancerous adenomas by postnatal day
(P) 12012,20 (Fig. 1a). Inflammatory infiltrate and Tgf-β1 accu-
mulation was evident at these sites of AAH and adenoma out-
growth (Fig. 1a, b). Although Tgf-β is a known driver of EMT
transcription factor expression and thus EMT, cells in AAH and
adenomas, as well as adjacent normal lung epithelium, continued
to express the epithelial specification protein E-cadherin, and they
failed to induce the mesenchymal marker Vimentin, indicating
they had not undergone EMT (Fig. 1c). By P150, the interior of
expanding adenomas showed evidence of hypoxia, detected by
immunostaining for EF5 (EF5+) (Fig. 1d). Within these regions,
small sites of intense EF5 immunostaining (EF5++) appeared
(Fig. 1e). These sites consisted of cell clusters at sites of Tgf-β1
accumulation that had undergone EMT, as evidenced by the loss
of E-cadherin and induction of Vimentin (Fig. 1f–i’). These
cluster cells displayed the decondensation of nuclear hetero-
chromatin, and in this way, were also distinct from surrounding
adenoma cells, which contained small nuclei with densely packed
chromatin (Fig. 1f–f”). By P170, the clusters had expanded, and
although blood vessels were evident in adenoma at the border of
the clusters, these hypoxic clusters themselves were devoid of
vessels (Fig. 1j, j’). At this age, cancer cells, characterized by large
euchromatic vesicular nuclei with an irregular contour and
nuclear enlargement, were scattered through the clusters
(Fig. 1j–j”). The clusters at P170 then contained cells with three
different nuclear morphologies: AD cells with small nuclei con-
taining densely packed heterochromatin, cancer cells with large
euchromatic nuclei, and intermediate cells (IC) with nuclear size
and heterochromatin content between adenoma and cancer cells
(Fig. 1j”). Clusters per adenoma are quantified in Fig. 1k, and IC
are the predominant cells within these clusters at P170 (Fig. 1k).
As the number of cancer cells increased, they formed dense foci
and began to display papillary structure (Fig. 1j, l–n). As opposed
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to the E-cadherin− IC, the cancer cells expressed E-cadherin and
thus did not show evidence of EMT, and by P220, they had
expanded into large tumors that invaded into airways (Fig. 1o–q).
Beyond nuclear morphology, the expression of IC also distin-
guishes them in both adenoma and cancer cells.
Consistent with their lack of E-cadherin and expression of
Vimentin, both characteristics of EMT, Zeb1, and CD44
expression were first observed in these hypoxic cell clusters
exclusively on IC (Fig. 2a–f). It has been demonstrated that Zeb1
represses transcription of the miR-200 family, which has been
shown to target mRNAs including CD44 and the CSC
transcription factor Bmi123–28. We reasoned that the transcrip-
tional repressor Zeb1, might be important for CD44 expression
via it repression of miR-200. In situ hybridization showed that
miR-200 is expressed in AAH, adenomas, and surrounding
normal lung (Fig. 2g), but it was repressed with Zeb1 induction in
clusters (Fig. 2h). As with CD44, Bmi1 was also induced with
miR-200 repression in clusters (Fig. 2i, j). Consistently, in cell
culture heterozygous mutation of Zeb1 in primary cultures of
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Fig. 1 Inflammation, Tgf-β1 accumulation, hypoxia, and EMT mark cancer cell-generating clusters in expanding adenomas. a H&E staining showing sites of
atypical adenomatous hyperplasia (AAH) originate around bronchial airways (AW), and then begin expanding into precancerous adenomas (AD) by P120
in K-Ras mutant mice. These sites are linked to infiltrating inflammatory cells. High concentrations of inflammatory cells are shown by black arrows, but
lower levels of these infiltrating cells have spread throughout the lung. b Sites of AAH, AD, and inflammation are rich in Tgf-β1. c Normal lung, AAH. and
AD express E-cadherin (E-cad). d Immunostaining for EF5 shows that by P150 the interiors of expanding AD are hypoxic (EF5+). e Highly EF5-positive
sites (EF5++) are present in the hypoxic interiors of expanding AD. f–f″ EF5++ sites represent small clusters of cells with decondensed chromatin.
Arrows in panel f show two such clusters surrounded by AD cells, which contain small nuclei with dense heterochromatin. Arrows in panels f′ and f″ show
the same location. g, g′ EF5++ clusters are sites of Tgf-β accumulation. Arrows show the same position in panels g and g′. h Consistent with EMT, loss of
E-cad marks cell clusters. Arrows show the outline of the cluster. i, i′ The mesenchymal marker Vimentin is induced in cell clusters. Arrows show the same
position in panels i and i′. j–j″ By P170, clusters have expanded. The yellow arrow in panel j shows cancer cells forming dense foci (see panel k). The white
arrows in panels j and j′ show the same position. “BV” are blood vessels within AD at the AD/cluster border. Note absence of BV within the cluster. Panel
j″ shows an AD cell with a small heterochromatin dense nucleus, a euchromatic AC cell containing a larger euchromatic vesicular nucleus with an irregular
contour and nucleolar enlargement, and a cell with an intermediate nuclear morphology evidenced by heterochromatin decondensation. These cells
displaying an intermediate nuclear morphology are termed intermediate cells (IC). k Hypoxic EF5++ clusters, first identified in panel e, were counted per
adenoma, and cell types were counted within clusters at P170 in four lungs (20 adenomas). l–n AC cells assemble into dense foci and form papillary
structures. The yellow arrow in panel l shows the same position in panel j. o, o′ By P220, AC cells had formed large tumors. p As opposed to IC, but similar
to adenoma cells, the tumors cells expressed E-cad and thus did not show evidence of EMT. q Invasion of expanding tumors into airways is shown. n > 5 for
each age. Bars are 50 μm
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knockdown was sufficient for induction of miR-200 and
repression of CD44 and Bmi1 mRNAs (Fig. 2k).
Zeb1 Repression of Zeb2 Removes a Block in Tgf-β1 Signaling.
Tgf-β classically induces Zeb1 to repress epithelial specification
genes such as E-cadherin during EMT25,29, implying Tgf-β1
accumulating at sites of tumor formation might be important for
driving EMT. Other EMT transcription factors, such as Snail, are
also induced by Tgf-β, but they rapidly decline and only Zeb1
maintains repression of epithelial genes during EMT induced by
Tgf-β30. Beyond repression of epithelial genes, mesenchymal
genes must be induced for full EMT, and mesenchymal genes,
such as Vimentin, are directly activated by Smads in response to
Tgf-β, demonstrating roles for Tgf-β signaling in both Zeb1-
mediated repression of epithelial genes and direct induction of
mesenchymal genes in EMT. Despite the widespread accumula-
tion of Tgf-β1, AAH, adenoma, and surrounding normal lung
continued to display an epithelial expression pattern (Fig. 1c),
implying Tgf-β1 signaling might somehow be blocked in these
cells, restricting Tgf-β1-driven EMT to cells in clusters.
Zeb1 and Zeb2 are related genes containing a common
repressor domain31, leading to the notion that Zeb2 functionally
overlaps with Zeb1 in cancer. However, Zeb2 contains a Smad-
binding domain that blocks R-Smad activity, and it was first
identified as Smad-interacting protein1 (Sip1)32. A switch from
Zeb2 to Zeb1 highlights malignant transition in melanoma, and
Zeb1 acted as an oncogene, whereas Zeb2 was a tumor suppressor
in xenographic transplants of melanoma cell lines33–35. These
results highlight opposing expression patterns and suggest
different roles for Zeb1 and Zeb2 in melanoma, but such a
transition from Zeb2 to Zeb1 has not been evaluated in lung
cancer, and it is unclear if any functional differences in melanoma
might be linked to Zeb2-mediated Smad inhibition. Nevertheless,
mutation of Zeb2 revealed it has a critical role in the inhibition of
Tgf-β family signaling to prevent competing mesoderm differ-
entiation during neuroectoderm formation36,37, demonstrating its
Smad inhibition is important in vivo during development.
As opposed to Zeb1, we found immunostaining for Zeb2 in
AAH, adenomas, and normal lung, and it was downregulated
with Zeb1 induction in hypoxic cell clusters forming in the
interior of adenomas (Fig. 3a, b). These results demonstrate a
Zeb2-to-Zeb1 switch linked to EMT, and they raised the
possibilities, first that elevated Zeb2 might be responsible for
blocking Tgf-β1 signaling in normal epithelium, AAH, and
adenomas, and thereby preventing EMT, and, second Zeb1
repression of Zeb2 might be responsible for their switch in
expression.
We turned to cell culture to examine these possibilities.
Knockdown or mutation of Zeb1 led to the induction of Zeb2
mRNA (Fig. 3c–e). But, knockdown of Zeb2 did not affect the
level of Zeb1 mRNA. Consistent with Zeb1 directly repressing
Zeb2, we found Zeb1 bound to the Zeb2 promoter in vivo using
chromatin immunoprecipitation assays, but Zeb2 was not
detected at the Zeb1 promoter in the cells (Fig. 3f). We concluded
that Zeb1 is directly repressing Zeb2.
Knockdown of Zeb1 led to the de-repression of E-cadherin
mRNA, and Tgf-β1 was then unable to repress its expression
(Fig. 3g). Tgf-β1 induction of Vimentin mRNA was also blocked
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Fig. 2 A CD44/Zeb1 loop marks IC. a Expression of Zeb1 is low in normal lung, AAH, and AD at P170. b CD44 is likewise low in normal lung, AAH, and AD
at P170. c, c′ Zeb1 is induced and E-cad is repressed in cell clusters. d, d′ CD44 and Vimentin are induced along with Zeb1 in cell clusters. Arrows indicate
the same position. e, e′ Zeb1 and CD44 are co-expressed in cell clusters. Arrows indicate the same position. f In cell clusters, CD44 is expressed on IC but
not AD or cancer cells (AC). g In situ hybridization showing miR-200 is low in normal lung, AAH, and AD. hmiR-200 is repressed in clusters. Arrows show
the border of the cluster. i Bmi1 is low in normal lung, AAH, and AD. j Bmi1 is induced in clusters. k Real-time PCR showing heterozygous mutation of Zeb1
in mouse embryo fibroblasts (MEFs) is sufficient for induction of miR-200, and repression of CD44 and Bmi1 mRNAs in cell culture. Bars are 50 μm
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Tgf-β1 induction of Zeb1 and Vimentin mRNAs. We concluded
that the level of Zeb2 accumulating in the absence of Zeb1 is
sufficient to block Tgf-β1 signaling, and thus Zeb1 repression of
Zeb2 is acting to relieve the inhibition of Tgf-β1 signaling.
Zeb2 Smad Inhibition Blocks Yap1 Nuclear Translocation.
Yap1 is a key target in regulating cell–cell contact inhibi-
tion26,38,39. In this capacity, it is required during the development
to block progenitor differentiation allowing outgrowth of forming
organs, and in cancer, it is oncogenic, critical for CSC generation
and it transitions tumor cells to Ras pathway independence40–42.
Activation of the Hippo pathway, for example, in response to
cell–cell contact, results in Rassf1a binding to Yap1, blocking its
interaction with Smad co-transcription factors that mediates
Yap1 nuclear translocation and function43. In response to Tgf-β
signaling, Rassf1a is degraded by Itch and it has been shown this
is sufficient for Yap1 association with Smads and nuclear trans-
location of a functional Yap1–Smad transactivation complex.
Nuclear Yap1 was not evident in AAH, adenomas, or
surrounding normal lung, but nuclear translocation occurred
specifically in hypoxic clusters where a Zeb2-to-Zeb1 switch
occurs in a Tgf-β1-rich environment (Fig. 4a–c). IL-6 is a key
downstream effector of Yap1 in progenitor cell expansion, and it
is directly targeted by Yap1 for induction in vivo44. IL-6 marks
sites of hypoxia in tumors, and its induction in early lesions is
necessary for unrestricted cancer cell outgrowth45. Consistent
with nuclear translocation of Yap1 in cell clusters, IL-6 induction
was evident in these cells (Fig. 4d).
In cell culture, as reported previously38, we found that Yap1
became sequestered in the cytoplasm as cells reached confluence,
and Tgf-β1 was unable to drive its nuclear translocation in these
confluent cells (Fig. 4e). In these confluent cells, expression of
Zeb1 mRNA was repressed and Zeb2 mRNA was induced
(Fig. 4f). But, with Zeb2 knockdown, Yap1 persisted in the
nucleus of confluent cells, and the cells lost contact inhibition
allowing their outgrowth into foci (Fig. 4e, g). We conclude that
Zeb2 is blocking nuclear translocation of Yap1. With Zeb1
knockdown, and the resulting elevation of Zeb2, Yap1 became
sequestered in the cytoplasm of subconfluent cells, and these
subconfluent cells stopped proliferation (Fig. 4h–j”). Taken
together, our results suggest that Zeb1 repression of Zeb2 is a
key focal point in the regulation of Tgf-β1 signaling, and nuclear
translocation of Yap1 is linked to cell proliferation.
Repression of Zeb2 Leads to Loss of Pten and Constitutive Akt
Phosphorylation. Zeb2 has been shown to act as a competitive
endogenous RNA that sequesters miRNAs normally targeting
Pten mRNA33. In this way, Zeb2 expression was shown to
maintain Pten. Consistent with these findings, we found Pten































































































































Fig. 3 Zeb1 represses Zeb2 to launch Tgf-β1 signaling capacity. a Immunostaining showing Zeb2 is high in normal lung, AAH, and AD. b Zeb2 is repressed
as Zeb1 is induced in clusters at P170. c Real-time PCR showing mutation of Zeb1 in cell culture leads to induction of Zeb2 and Pten mRNAs. dWestern blot
showing that Zeb1 protein expression parallels mRNA levels with Zeb1 mutation. e Lentivirus shRNA knockdown of Zeb1 leads to induction of Zeb2 mRNA,
and knockdown of Zeb2 causes loss of Pten mRNA in cell culture. f Chromatin immunoprecipitation analysis showing Zeb1 is bound to the Zeb2 promoter
in vivo. g The level of Zeb2 accumulation in the absence of Zeb1 is sufficient to block Tgf-β1 signaling in cell culture. Cells were treated with 75 pM Tgf-β1
for 12 h. “Control” indicates cells were infected with a lentivirus containing a scrambled shRNA sequence (Methods). Bars are 50 μm
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In culture, Zeb1 mutation or knockdown led to induction of Pten
mRNA (Fig. 3c, e). Conversely, Zeb2 knockdown led to the loss of
Pten mRNA (Fig. 3e). We then concluded that de-repression of
Zeb2 following Zeb1 loss is responsible for this induction of Pten.
Pten inhibits PI3K activity, preventing downstream PI3K-
initiated mTocr2 activating phosphorylation of Akt on S473
(pS473Akt)15. Consistent with the loss of Pten in hypoxic clusters,
pS473Akt accumulated in these cells (Fig. 5a–c). And, knockdown
of Zeb2, leading to loss of Pten in culture, caused constitutive
pS473Akt (Fig. 5d–e”). pS473Akt inhibits apoptosis, and it can
prevent cell death when adhesion-dependent cells are placed in
suspension culture (anoikis)46. Consistent with constitutive
pS473Akt upon Zeb2 knockdown, these cells showed increased
survival in suspension (Fig. 5f).
Nuclear Polarization of Transcription Factors in Mitosis
Establishes Parent and Daughter Fates Prior to Cytokinesis as
Adenoma Cells Divide Asymmetrically to Generate IC. The
appearance of IC in the interior of expanding adenomas suggested
that they might be derived from adenoma cells. Dividing cells in
hypoxic clusters at P170 were confirmed by Tubulin immunos-
taining of mitotic spindles, and cells displaying patterns of mitosis
or cytokinesis were included (Fig. 5g). We identified mitotic cells
where one forming pole displayed decondensed chromatin
indicative of IC, whereas the opposite pole retained condensed
chromatin of adenoma cells (Fig. 5g). In these mitotic cells, Zeb1,
Bmi1, and Yap1 were restricted to decondensed chromatin,
whereas Zeb2 was associated exclusively with compacted chro-
matin in the opposite pole. And, this polarization of the tran-
scription factors persisted during cytokinesis (Fig. 5g). Consistent
with this early nuclear polarization of transcription factors in
mitosis driving gene expression patterns that distinguish parent
adenoma cells and daughter IC, the pole of the dividing cells with
Zeb2+ compact chromatin already showed an E-cadherin+,
CD44−, Pten+, pS473Akt− pattern of parent adenoma cells
during cytokinesis, whereas the opposite pole with Zeb1+, Bmi1
+, Yap1+ decondensed chromatin had transitioned to an E-
cadherin−, CD44+, pS473Akt+ pattern of daughter IC (Fig. 5g).
We concluded that adenoma cells are dividing asymmetrically to
generate IC, and nuclear polarization of transcription factors
during mitosis is driving opposing target gene expression patterns,
which define parent adenoma cells and daughter IC, in opposite
poles of the cell before cell division is completed.
Numb is required for asymmetric division47. It binds to E-
cadherin in the parental pole of asymmetrically dividing cells
causing cytoskeletal rearrangements that drive unequal distribu-
tion of cellular content to daughter cells48. In this context, Numb
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Fig. 4 Zeb2 blocks nuclear translocation of Yap1. a Immunostaining showing Yap1 is not concentrated in the nucleus in normal lung, AAH, and AD. b A
cluster forming in the interior of an AD at P170. Arrows show the cluster border. c Yap1 is translocated to the nucleus in clusters. d The downstream target
of Yap1, IL-6, is induced with nuclear translocation of Yap1 in clusters. e Cells in culture were allowed to reach confluence, and were then treated with 75
pM Tgf-β1 for 12 h. Note the block in Yap1 nuclear translocation at confluence. Similar cytoplasmic retention of Yap1 was evident at confluence in the
absence of Tgf-β1. Zeb2 shRNA knockdown maintains nuclear Yap1 at confluence. f Real-time PCR showing Zeb1 mRNA is repressed and Zeb2 mRNA is
induced when cells are allowed to become confluent. g Control cells remain growth-arrested at confluence, but knockdown of Zeb2 allows continued
proliferation and cell outgrowth into foci. h Knockdown of Zeb1 leads to loss of proliferation and senescent morphology29. i–i″ Yap1 is nuclear in
subconfluent control cells. j–j″ Yap1 becomes sequestered in the cytoplasm of subconfluent cells when Zeb1 is knocked down. Bars are 50 μm in panels
a–e, and 25 μm in panels f–j
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asymmetrically dividing stem cells and CSC. Recent evidence
demonstrates that asymmetric division is regulated by miRNAs
targeting Numb mRNA, and miR-34a directly targets Numb
mRNA, and repression of miR-34a by inflammation induces
Numb to promote asymmetric division49,50. In addition to miR-
200, Zeb1 represses miR-34a, and this loss of miR-34a was shown
to drive cytoskeletal changes51. We did not detect Numb in Zeb1−
adenoma cells, but it was induced with Zeb1 in mitotic adenoma
cells giving rise to IC, and it co-localized asymmetrically with E-
cadherin in the parental “adenoma-like” pole of these dividing
cells (Fig. 5g, h).
As expected, adenoma cells distal to hypoxic clusters divided
symmetrically to produce additional adenoma cells with the same
nuclear morphology and expression pattern, consistent with the
observed expansion of adenomas in the lung (Fig. 5h).
IC in Clusters Divide Symmetrically to Expand Their Number.
We identified other dividing cells in clusters at P170 that did not
display nuclear polarization, and showed uniform chromatin
decondensation of IC in both poles. Accordingly, these dividing
cells maintained the E-cadherin−, Zeb1+, CD44+, Zeb2−,
Pten−, pS473Atk+, Bmi1+, nuclear Yap1 pattern of IC in both
poles (Fig. 5i). These results demonstrate symmetric division of
IC to produce additional daughter IC accounting at least in part
for the increase in cluster size from P150 to P170 (Fig. 1f, j, k).
IC are Initial Cancer-generating Cells (CGC). We then exam-
ined clusters for evidence that IC might be dividing to produce
cancer cells. A second form of nuclear polarization was evident in
dividing cells in clusters at P170. Partially decondensed chromatin
representative of IC was evident in one pole of these cells in
mitosis, whereas euchromatin indicative of cancer cells was pre-
sent in the opposite pole (Fig. 6a). Zeb1 was enriched in decon-
densed chromatin, and this pole of the cell maintained the E-
cadherin− and CD44hi pattern of IC. The opposite pole of the cell
































































































Fig. 5 Pten loss and pS473Akt induction mark clusters, Zeb2 knockdown causes pS473Akt and resistance to anoikis, and asymmetric division of adenoma
cells generates IC. a Immunostaining showing Pten in normal lung, AAH, and AD. b Immunostaining showing pS473Akt is low in normal lung, AAH, and
AD. c Repression of Pten and induction of pS473Atk marks clusters. d–e″ In cell culture, shRNA knockdown of Zeb2 causes constitutive pS473Akt.
d shows a higher cell density region. GFP is expressed from the lentivirus. The control virus had no effect of pS473Akt. f Consistent with the anti-apoptotic
properties of pS473Akt, Zeb2 knockdown cells, displaying constitutive pS473Akt, showed increased survival (resistance to anoikis) when placed in
suspension culture for 48 h. Bars are 50 μm. g Dividing cells in clusters were identified by immunostaining for Tubulin (Tub)+ mitotic spindles. Cells
displaying patterns of mitosis or cytokinesis, as well as the morphology of dividing cells, were examined. We noted mitotic cells where one pole displayed
dense heterochromatin of AD cells, whereas the opposite pole showed decondensed chromatin of IC. Immunostaining showed that Zeb1, Yap1, and Bmi1
co-localized with decondensed chromatin, whereas Zeb2 was restricted to dense chromatin. This transcription factor polarization persisted in cytokinesis.
The pole of the dividing cells with Zeb2+ compact chromatin showed an E-cadherin+, CD44−, Pten+, pS473Akt− pattern of parent adenoma cells during
cytokinesis, whereas the opposite pole with Zeb1+, Bmi1+, Yap1+ decondensed chromatin had transitioned to an E-cadherin−, CD44+, pS473Akt+
pattern of daughter IC. Notably, Numb, which was not evident in adenoma cells, was induced in the dividing cells and it co-localized asymmetrically with
E-cadherin during cytokinesis. h Outside of EF5+ regions in AD, AD cells divide symmetrically to produce AD daughters. i We identified other dividing cell
in clusters that did not display nuclear polarization, and showed uniform chromatin decondensation in both poles. These dividing cells maintained the
E-cadherin−, Zeb1+, CD44+, Zeb2−, Pten−, pS473Atk+, Bmi1+, nuclear Yap1 pattern of IC in both poles. Although Numb was maintained in these
dividing IC, it was symmetrically distributed. Cells type and number of dividing cells in clusters is quantified in Fig. 1k
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04663-1 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:2424 | DOI: 10.1038/s41467-018-04663-1 | www.nature.com/naturecommunications 7
pattern of cancer cells. By contrast to Zeb1, Bmi1 and Yap1 were
equally distributed in the decondensed chromatin and euchro-
matin of both poles, and both poles maintained a Zeb2−, Pten−,
pS473Akt+ pattern (Figs. 5g, h and 6a). Numb expression was
asymmetric in these dividing cells, where it co-localized with E-
cadherin in the pole displaying euchromatin (Fig. 6a, c). A Zeb1lo,
CD44lo, E-Cadherin+, Zeb2−, Pten−, pS473Akt+, Bmi1+,
nuclear Yap1+ pattern was maintained in cancer cells as they
divided symmetrically to form papillary tumors (Fig. 6b, d–f).
Numb expression was maintained in the cancer cells, but was
equally distributed to both poles as these cells divided symme-
trically (Fig. 6b, c). Consistent with ongoing repression of miR-
200, the cancer cells were Bim1+, but they were CD44lo (Fig. 6g,
h). Thus, whereas ongoing repression of miR-200 in the cancer
cells was sufficient for continued expression of Bmi1, it was not
sufficient to maintain CD44hi. It then appeared a high level of
Zeb1 might be necessary to maintain CD44 through a miR-200-
independent pathway, or CD44 expression is reduced in cancer
cells via a dominant Zeb1-independent mechanism (see below).
We concluded that IC divide asymmetrically to produce cancer
cells, and they are thus initial CGC. Nuclear polarization of
transcription factors again highlighted parent CGC and daughter
cancer cells fates during mitosis. It then appears these CGC are a
stable population bridging the gap between precancerous and
malignant cells. Numb-highlighted asymmetric and symmetric
divisions in clusters are quantified in Fig. 6c.
Invading Cancer Cells Display Plastic EMT, but Fail to Induce
CD44 or Display Properties of CGC. We reasoned one expla-
nation for the Zeb1lo, CD44lo pattern, and lack of EMT in the
cancer cells (Fig. 6a–g) might be they are moving away from sites
of hypoxia and Tgf-β1 accumulation as they expand into tumors.
Notably, subsequent invasion of expanding tumors into airways
occurs at sites of inflammation and Tgf-β1 accumulation (Fig. 7a,
b), and we found that immunostaining for Zeb1 was increased in
these invading cells and the cells had undergone EMT as evi-
denced by loss of E-cadherin (Fig. 7c–e). Based on our findings in
cell culture, we suggest that ongoing repression of Zeb2 in the
cancer cells allows the cells to respond to Tgf-β1 concentrated
around airways and induce Zeb1 and EMT to facilitate invasion.
However, despite this induction of Zeb1 and EMT and continued
repression of miR200, the invading cancer cells remained CD44lo
(Fig. 7f), they did not show evidence of EF5++ clusters, a
decondensed chromatin pattern resembling CGC, and we did not
observe asymmetric distribution of Numb in any of the invading
cells undergoing division (Fig. 7g). We conclude that EMT in
cancer cells is plastic and linked to inflammatory infiltrate, Tgf-β1






























































Fig. 6 IC in clusters are cancer-generating cells (CGC). a In Fig. 5g, we identified AD cells dividing to produce IC daughters. We also noted a second form of
nuclear polarization in dividing cells in clusters at P170. Partially decondensed chromatin indicative of IC was evident in one pole of these cells, whereas
euchromatin indicative of cancer cells was present in the opposite pole. Zeb1 was enriched in decondensed chromatin, and this pole of the cell maintained
the E-cadherin- and CD44hi pattern of IC. The opposite pole of the cell with Zeb1lo euchromatin displayed the E-Cadherin+ and CD44lo pattern of cancer
cells (AC), and Numb asymmetrically co-localized with E-cadherin. By contrast to Zeb1, Bmi1 and Yap1 were equally distributed in the decondensed
chromatin and euchromatin of both poles, and both poles maintained a Zeb2−, Pten−, and pS473Akt+ pattern. We conclude parent IC are dividing to
produce daughter AC, and they are therefore cancer-generating cells (CGC). b We identified symmetrically dividing cancer cells that displayed
euchromatin as well as the same Zeb1lo, CD44lo, E-Cadherin+, Zeb2−, Pten−, pS473Akt+, Bmi1+, nuclear Yap1+ pattern in both poles. c Quantification of
different cell divisions occurring in clusters. AD, CGC, and AC cells were identified in clusters by nuclear morphology and expression patterns. AD= Zeb2+,
E-cad+; CGC= CD44hi; AC= Zeb2−, E-cad+. n= 10 clusters were averaged at P170. d Expanding tumors display papillary morphology and are
E-cadherin (E-cad)+. e These E-cad+ tumors cells remain Zeb1lo. f Tumor cells are Pten− and Zeb2−. g CD44 expression is low on the tumor cells. h In
situ hybridization shows that tumors cells are miR-200−. Bars are 50 μm
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But, this induction of Zeb1 does not restore a CD44hi CGC-like
population among the invading cancer cells. Thus, it appears that
the Zeb1/CD44 loop evident in CGC is disrupted by stable Zeb1-
independent repression of CD44 that is initiated as cancer cells
are generated.
Zeb1 is Required for CGC Generation. We have shown that
Zeb1 is important for tumor progression in K-Ras-initiated lung
cancer20. But, the mechanism was unknown, and we concluded
that the effects were likely due to a classic role for EMT in cancer
cell behavior (e.g., migration and invasion). However, our results
above raised the possibility that Zeb1 in the context of a CD44/
Zeb1 loop might be critical for CGC formation and in turn cancer
cell generation. Knockout of Zeb1 leads to late embryonic leth-
ality, and its loss causes changes in developing epithelial field
borders29,52. Heterozygous mutation of Zeb1 does not affect
viability, but the mice develop posterior corneal dystrophy,
demonstrating that simply lowering the level of Zeb1 is impactful
in vivo53. And, we show here that heterozygous mutation or Zeb1
knockdown causes repression of CD44 and induction of Zeb2,
suggesting this threshold level of reduction in Zeb1 is sufficient to
deregulate genes marking the transition to CGC.
K-Ras mice were crossed into a Zeb1(+/−) background
(Methods). The reduced level of Zeb1 had no effect on adenoma
formation, or generation of hypoxia in interiors of expanding
adenomas (EF5+) at P170 (Fig. 8a). But, small intensely EF5++
hypoxic sites indicative of cluster cells were inhibited, and
accordingly, clusters of cells displaying decondensed chromatin
failed to form (Fig. 8a). In turn, CD44 was not induced, Zeb2 was
not repressed, and cells displaying an E-cadherin−, Pten−
pattern of EMT were diminished in adenomas. Consistent with
this inhibition in the formation of CGC, cancer cell number was
inhibited as was AC outgrowth at P220 (Fig. 8a, b).
Lentivirus co-expressing GFP and Zeb1 shRNA, or a control
sequence (Methods), was delivered intratracheally every 2 weeks
into K-Ras mice beginning at P30 and ending at P90. Mice were
then analyzed at P170, and using GFP as a marker, virus
efficiently infected normal lung tissue (Fig. 8c). We did not
detect a difference in GFP+ adenoma formation or transition of
the interiors of these expanding adenomas to hypoxia (EF5+),
but EF5++ clusters were inhibited as was cancer cell
generation (Fig. 8d). We concluded that a threshold of Zeb1
induction is necessary to drive adenoma cells to produce CGC,















































































Fig. 7 Invading cancer cells display plastic EMT, but fail to induce CD44 or show properties of CGC. a Sites of airway invasion show inflammation (arrow).
b Sites of tumor invasion are Tgf-β1-rich and remain Pten−. c Zeb1 is re-induced in tumor cells at sites of airway invasion. d E-cadherin (E-cad) is repressed
in tumor cells at sites of airway invasion, but it is maintained in airway epithelial cells (arrow). e Higher power view of Zeb1+, E-cad− tumor cells invading
an airway. The arrow indicates E-cad+ airway epithelial cells. f Invading tumor cells continue to be CD44lo. g Quantification of cell morphology, expression,
and division patterns in invasive and non-invasive tumors. n= 18 at P220. Bars are 50 μm
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Characterization of CD44hi Cells from Lung Tumors. We
attempted to isolate and compare adenoma, CD44hi CGC, and
cancer cells from K-Ras initiated tumors. First, we noted that
neither adenoma cells at P150 nor cancer cells at P225 survived
when lungs were dissociated and placed in cell culture. And, we
found that CD44hi cells in these primary cultures, or following
sorting of dissociated lung tissue for CD44, rapidly lost CD44 in
culture, and the cells failed to proliferate. p53 has been shown to
repress CD44, and this repression of CD44 is important for p53
tumor suppression and cell growth arrest11. Progressive p53
induction in primary rodent cell culture is classically responsible
for cell senescence. Even though p53 does not appear to affect
cancer cell generation or proliferation in K-Ras tumors
in vivo18,19, we hypothesized that its induction under the stress of
culture was responsible for blocking CD44 expression and via-
bility in culture.
Notably, a small subset of cells was shown previously to expand
when K-Ras, p53 compound mutant tumors were placed in
culture, and these cells were highly tumorigenic when delivered
intratracheally back into WT lungs51. Here, we show that this
subset of cells surviving in culture from K-Ras, p53 compound
mutant tumors are the CD44hi population (Fig. 9a, b). As with
CGC, these CD44hi cells displayed a Zeb1+, Zeb2−, Pten−,
pS473Atk+ pattern (Fig. 9c–g). Knockdown of Zeb1 lead to
induction of Zeb2, and in turn, induction of Pten with loss of
constitutive pS473Akt. This induction of Zeb2 also led to a block
of Tgf-β1 signaling (Fig. 9c). Notably, knockdown of Zeb1 in
these CD44hi cells led to cell senescence (Fig. 9h, i), demonstrat-
ing they have become addicted to Zeb1. Taken together, these
results suggest that p53 is a barrier to the culture of CD44hi CGC,
and, even with p53 mutation, these CD44hi cells represent the
small population in the lungs that is viable in culture.
A ZEB2 and PTEN Signature Predict Survival in Lung AC. Our
results point to downregulation of Zeb2 as a key initiating event
in loss of Pten expression and in unleashing Tgf-β1 signaling.
This Zeb2−, Pten−, pattern established in cancer-generating
cluster cells, persists in cancer cells. Notably, loss of Zeb2 pro-
vides a mechanism for Pten repression that is a hallmark of AC,
where Pten is not mutated. In line with our findings in the mouse,
both ZEB2 and PTEN mRNAs were downregulated in human
lung AC with a Ras pathway mutation (Fig. 10a), and there was a
linear correlation between their expression in the tumors
(Fig. 10b), implying the same linkage in their expression we found
in mouse lung tumors and cells in culture. Consistent with the
importance of ZEB2 and PTEN, their co-expression was a
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Fig. 8 A threshold level of Zeb1 is required for CGC formation and cancer cell generation. a Quantification of the effects of heterozygous mutation of Zeb1
on CGC at P170. EF5+ and EF5++ sites are described in Fig. 1d, e, k. CGC and AC cells in clusters were identified by nuclear morphology and expression
patterns. CGC= CD44hi; AC= Zeb2−, E-cad+. b Heterozygous mutation of Zeb1 does not affect AD formation, but it inhibits AC. c, d Zeb1 shRNA or
control lentivirus was delivered intratracheally biweekly beginning at P30 and ending at P90. Then, lungs were examined at P170. Panel c shows efficient
infection of the lung assessed by GFP expressed from the virus. Quantification of the effect of the Zeb1 shRNA on EF5++ cluster formation and generation
of AC cells in the EF5+ regions of AD is shown. EF5++ clusters and AC cells observed were GFP−, indicating they had arisen from uninfected cells. The
bar is 50 μm
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Discussion
Mutation of K-Ras leads to a prolonged period of precancerous
adenoma outgrowth in the mouse lung, followed by cancer cell
generation in the hypoxic, Tgf-β1-rich interiors of these
expanding lesions (Fig. 10d–f). These cancer cells, in turn, pro-
liferate into large AC that invade airways (Fig. 10g). We identify a
two-step pathway where precancerous cells divide asymmetrically
to produce an intermediate population of CGC, which in turn,
divide asymmetrically to produce cancer cells. Studies of mam-
malian asymmetric division mechanism have largely focused on
cell polarization causing the mitotic plane in driving cells to
unequally partition cytoplasmic contents into daughter cells in a
Numb- and Par-mediated process54. However, studies of asym-
metric division in flies and worms have shown differences in
heterochromatin on the two DNA strands arising during the S
phase, linking fate of the two daughter cells to differential seg-
regation of these sister chromatids based on heterochromatin
content55–57. A DNA replication-mediate process highlighted by
differential loading of new unmodified histones on leading vs.
lagging DNA strands was proposed to drive the heterochromatin
differences in sister chromatids, and these differences in histone
modifications in turn allowed mother and daughter centrosomes
to segregate sister chromatids based on heterochromatin content
into the two daughter cells. The implication being that resulting
differences in heterochromatin content would be expected to
regulate differential transcription factor binding, gene expression,
and thus phenotype in the daughter cells. Although our studies
lack the mechanistic detail found to drive differential hetero-
chromatin assembly on sister chromatids in asymmetrically
dividing fly and worm stem cells, we provide consequential and
complimentary evidence that similar asymmetric hetero-
chromatin assembly in sister chromatids actually drives mitotic
polarization of key transcription factors including Zeb1 in cancer
cell initiation. And, we provide linked evidence that this mitotic
polarization of transcription factors has already produced asym-
metric expression of their key target genes in opposite poles of the
cell before cytokinesis.
CGC arise at hypoxic sites in expanding adenomas and are
marked by EMT and a CD44/Zeb1 loop. Disruption of this loop
by mutation or knockdown of Zeb1 eliminates CGC formation
from adenoma cells, thereby inhibiting cancer cell production.
Notably, hypoxia induces expression of Zeb158, and Zeb1
repressor activity and its function in EMT are mediated through
interaction with the NADH-dependent co-repressor CtBP59.
Hypoxia-driven aerobic glycolysis, leading to NADH generation,
then allows CtBP, and in turn Zeb1, to act as an oxygen/metabolic
sensor60–62. Zeb1 repression of Zeb2 in these cells leads to the

































































Fig. 9 CD44hi cells from K-Ras/p53 compound mutants. a Immunostaining demonstrating the viable cells from K-Ras, p53 mutant tumors are CD44hi.
b Real-time PCR showing that the viable cells in culture are the CD44 mRNA high fraction of the lung tumors. c Real-time PCR showing that knockdown of
Zeb1 in cells from a leads to induction of Zeb2 and Pten mRNAs, and with this increase in Zeb2, Tgf-β1 signaling is inhibited. d–d″ Lentiviral infection with
Zeb1 shRNA (expressing GFP) causes induction of Zeb2. e Knockdown of Zeb1 leads to induction of E-cadherin (E-cad). f With the increase in Zeb2 upon
Zeb1 knockdown, Pten is induced. g Pten induction following Zeb1 knockdown leads to loss of constitutive pS473Akt. h, i Knockdown of Zeb1 leads to loss
of cell viability. GFP+ cells show the large, flattened, and multi-nucleated morphology of senescent cells, and according the cells stained for senescent
β-galactosidase, as described29
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AC, and it releases Smad inhibition allowing Tgf-β1 signaling to
drive nuclear translocation of the CSC transcription factor Yap1.
Division of these CD44hi, Zeb1hi cells generates CD44lo, Zeb1lo
cancer cells. The reduced level of Zeb1 in the cancer cells is not
sufficient to maintain repression of E-cadherin, and EMT is
reversed. However, the level of Zeb1 was still sufficient to
maintain repression of Zeb2, allowing the cancer cells to respond
to Tgf-β1 accumulating at sites of inflammation and airway
invasion to re-establish Zeb1hi and EMT in the invading cells. We
suggest that this constitutive repression of Zeb2 leads to plastic
EMT in the cancer cells dictated by inflammation and Tgf-β1
accumulation concentrated around airways.
Despite the restoration of a Zeb1hi level in invading cancer
cells, the cells remained CD44lo and we failed to detect cells
with properties of CGC within the tumors. We interpret these
findings to mean that cells with properties of CSC are not being
generated from existing cancer cells in this model. Notably,
migrating cells with properties of CSC are also linked to metas-
tasis, and despite the formation of large invasive AC, no metas-
tasis was evident in this K-Ras model. As noted above, attempts
to isolate CD44hi CGC by flow or simply observing the cells
after tumor dissociation in cell culture led to rapid loss of
CD44 expression and failure of the cells to expand in culture. In
contrast to the K-Ras model, a small subset of cells could be
cultured from K-Ras, p53 compound mutant tumors, and these
cells were highly tumorigenic when delivered intrathecally into
the lung51. Here, we demonstrate these cells correspond to a
CD44hi subset of the tumors. p53 represses CD44, and we
conclude that p53 induction in culture, which is classically
responsible for senescence in primary rodent cell cultures, is likely
causing the loss of CD44 expression and failure of expansion
of the cells in culture. Evidence suggests that CSC in tumors
are derived from existing cancer cells that undergo reversible
p53-regulated reprogramming, and they are important for
ongoing tumor expansion and tumor renewal following therapy.
Indeed, p53 mutation is required for a CSC pool in mouse
breast cancer63. p53 triggers stable repressive epigenetic chan-
ges64, and we suspect p53 in expanding cancer cells in the K-Ras
model is responsible for maintaining CD44 silencing, even as
Zeb1 is re-induced during the invasion (Fig. 10f, g). In this
regard, Numb sustains high p53 activity65, and notably it was
expressed in cancer cells, where it was symmetrically distributed
along with E-cadherin in the dividing cells (Fig. 6b). We suggest
this inability to induce CD44 in the cancer cells prevents their
reprogramming to CSC until p53 is mutated. Although it remains
to be seen how the CD44hi, Zeb1hi CGC we identify as initial
CGC within adenomas might be related to CSC, we propose CSC
generation from existing cancer cells reflects reprogramming
aimed at restoring the cancer cell-generating phenotype
of CGC.























































































































Fig. 10 A ZEB2, PTEN predicts survival in human lung AC, and model of precancerous lesion transition to lung cancer. a Box plot showing expression of
ZEB2 and PTEN mRNAs in human lung AC. The top of the box is the 75 percentile, whereas the bottom is the 25 percentile. The bar indicates the median
and whiskers the highest and lowest values. K-Ras+ and EGFR+ indicate mutations confirmed by sequencing, and “Normal” indicates adjacent uninvolved
lung tissue. b Pearson plot demonstrating a linear correlation between ZEB2 and PTEN mRNA levels in tumors in a. c Survival curves showing a ZEB2, PTEN
expression signature predicts survival in human lung AC. d Precancerous adenoma (AD) lesions. K-Ras mutation triggers cell proliferation leading to the
outgrowth of lung epithelial cells into AAH and AD. Red “X” indicates a block. The blue line running through K-Ras shows that, when activated, Yap1 can
bypass the ongoing requirement for K-Ras mutation in tumors40–42. Dashed lines indicate inactivated pathways, whereas solid lines show activated
pathways. The font size of Zeb1, Smad, and Yap1 depict relative level of expression or activation. e Cancer-generating cells (CGC). Hypoxia and Tgf-β1
accumulation in the interior of expanding AD triggers formation of CGC. f Cancer cells. As cancer cells form from CGC and migrate away from Tgf-β1-rich
hypoxic clusters, Zeb1 expression diminishes. This lower level of Zeb1 is sufficient to maintain repression of miR-200 and induction of Bmi1, and repression
of Zeb2 leading to repression of Pten and nuclear Yap1. But, this lower level of Zeb1 is not sufficient to maintain EMT. And, CD44 is low in the cancer cells,
consistent with its dominant repression by p53. g Invasive cancer. As cancer cells encounter Tgf-β1-rich airways, Zeb1 is induced and the cells again
undergo EMT. This depicts plastic EMT in cancer cells linked to invasion. But, this induction of Zeb1 in invading cancer cells does not lead to re-expression
of CD44 or asymmetry of heterochromatin, Numb, and transcription factors in poles of dividing cells, as with CGC
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Methods
RNA Extraction and Real-time PCR. RNA was extracted using TRIzol, and cDNA
was synthesized using the Invitrogen RT kit (Invitrogen), and SYBR Green real-
time PCR was performed using a Stratagene Mx3000P Real-time PCR system20.
PCR primer sequences and annealing conditions are shown in Supplementary
Table 1. Three independent samples, each in triplicate, were analyzed for each real-
time PCR condition. The detection of miRNAs was described previously24. Briefly,
polyadenylation of at least 5 µg of total RNA was completed by poly(A) polymerase
kit (PAP, Ambion) in 20 µl of reaction volume according to manufacturer’s
instruction. The polyadenylated RNA was thereafter directly utilized for cDNA
preparation using a reverse transcription kit (M-MLV reverse transcriptase, Invi-
trogen) and an adaptor primer (5′-GCGAGCACAGAATTAATACGACTCACT
ATAGG(T)12VN*-3′) in 40 µl of reaction volume. Real-time quantitative PCR was
performed using a universal primer (5′-GCGAGCACAGAATTAATACGAC-3′)
and a miRNA-specific primer (Supplementary Table 2). Tgf-β1 was from Bio-
Source, Camarillo, CA.
Immunostaining and In Situ Hybridization. Images were captured with a Zeiss
Axio Imager.M2 microscope equipped with ApoTone.2 using a X-cite series 120Q
light source, and AxioCam ICc3 and AxioCam MRm cameras. Images in the Zeiss
Zen imaging program were transferred to Powerpoint for figure assembly. Only
brightness and contrast were modified. Then a PDF was created. Immunostaining
was performed as described previously29. Antibodies and conditions are described
in Supplementary Table 3. EF5 staining for hypoxia was described previously66. For
in situ hybridization, mouse lung tissues were fixed in 10% formalin solution
immediately after removal, and then paraffin-embedded and sectioned at 10 µm.
Locked nucleic acid-modified, double-digoxigenin (DIG)-labeled DNA probes were
purchased from Exiqon (Denmark) and in situ hybridization was performed as we
have described67. Briefly, the paraffin-embedded slides were deparaffinized and
then treated with protease K. The probes were hybridized to the sections at 57 °C
after dehydration, and then detected by an antibody against DIG conjugated with
Cy3 (Jackson ImmunoResearch). miR-200 probes were described67.
Chromatin Immunoprecipitation Assays. Primers, antibodies, and conditions for
chromatin immunoprecipitation using Zeb1 and Zeb2 antibodies were described
previously20,67.
Cell Culture. Primary cultures of Zeb1 mutant embryo fibroblasts were isolated as
described29. Cells were cultured in Dulbecco's modified ealgle media (DMEM) with
10% heat-inactivated fetal bovine serum, or serum starved for 12 h prior to -β
treatment. When lung tumors from K-Ras, p53 compound mutants were placed in
culture, a small subset of these tumor cells survived and proliferated in culture, and
these cells were highly tumorigenic when delivered intratracheally back into WT
lungs51. These cells were grown in DMEM with 10% heat-inactivated fetal bovine
serum. We found that this population was CD44hi.
shRNA Knockdown. We have described lentiviral shRNA knockdown of Zeb1 and
Zeb2 protein and mRNAs in detail previously20,24,53,67. Three shRNA lentiviruses
with different Zeb1 and Zeb2 shRNA sequences from Open Biosystems were used
for knockdowns with similar effects. Lentivirus with a scrambled shRNA sequence
5′-CAACAAGATGAAGAGCACCAATCTCTTGAAT TGGTGCTCTTCATCT
TGTTG-3′ was used as a control—this control sequence was blasted against all
mouse RNA sequences to ensure that it did not target an mRNA.
Mutant Mice. Housing and handling of all mice were in accordance with proce-
dures approved by the University of Louisville Institutional Animal Care and Use
Committee (IACUC). K-rasLA1 mice12 in a C57BL/6 background were obtained
from Jackson Laboratory. These mice were crossed with Zeb1(+/−) mice29 also in
a C57BL/6 background to yield K-RasLA1, Zeb1(+/+), and K-RasLA1, Zeb1(+/−)
mice. Lungs were obtained for histological analysis of tumors at the indicated ages.
PCR genotyping was as described previously20. Tumor pathology was evaluated
blindly by an experienced pathologist (M.C.). p53 mutant mice in a C57BL/6
background were also crossed to the latent K-RasLA1 mice above and lung tumors
were trypsinized and placed in cell culture in DMEM with 10% fetal bovine serum.
A small fraction of cells survived, and RNA was isolated from these cells and
starting lung tumor tissue for real-time PCR analysis of CD44 mRNA expression.
For lentiviral ZEB1 shRNA or control shRNA treatment, K-RasLA1 mice at
1 month of age were anesthetized by IP injection of a combination of ketamine
(100 mg/kg) and xylazine (10 mg/kg). The anesthetized mouse was placed on a
warm platform in a biosafety hood. The mouth was opened by gently pulling the
upper two front teeth, the tongue was extended by the forceps, and an Excel Saflet
IV catheter was placed in the trachea. A total 50 µl of DMEM cell supernatant with
a viral titer of approximately 1 × 109 lentiviral particles was slowly delivered into
the lung. The treated mice were then housed in a biosafety room, and closely
monitored daily in accordance with protocols approved by the Institutional Animal
Care and Use Committee. This tracheal viral delivery was repeated every 2 weeks
until the animals were 3 months of age.
Animal number estimates were based on our previous studies using the K-Ras
model20. Based on these previous studies, we did not detect any differences with
regard to sex, thus male and female mice were chosen at random.
Human Lung AC Microarray and Tissue Analysis. Microarray data for human
lung AC sequenced for mutations in K-RAS and EGFR, and patient-matched
control lung tissue was obtained from the NCBI database (GSE_11969). Data were
corrected for background and normalized to median fluorescence and GAPDH
expression. Box plots were done as described33.
Statistical Analysis. Significance was determined by Student’s t test. Error bars in
figures represent standard deviations. For survival curves, a logrank test was used to
generate p values with the GraphPad Prism program.
Data availability. All relevant data are available from the authors.
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